An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
